Leverkusen, Germany

Ervin Horváth

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bayer Healthcare Aktiengesellschaft. Active years: 2011.



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ervin Horváth: Innovator in Medicinal Chemistry

Introduction

Ervin Horváth is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His research focuses on developing novel compounds that can be utilized in therapeutic applications.

Latest Patents

One of Ervin Horváth's key patents is titled "Cylopenta[b]benzofuran derivatives and the utilization thereof." This patent relates to a new class of cyclopenta[b]benzofuran derivatives, detailing processes for their preparation and their application in the manufacture of medicaments. These compounds are particularly aimed at addressing acute or chronic disorders characterized by elevated cellular stress, local or systemic inflammatory processes, or hyperproliferation. This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Ervin Horváth has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bayer Healthcare and Intermed Discovery. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ervin has collaborated with several professionals, including Nicole Diedrichs and Thomas Fahrig. These partnerships have enriched his research and facilitated the development of innovative solutions in medicinal chemistry.

Conclusion

Ervin Horváth's contributions to the field of medicinal chemistry through his patent work and collaborations underscore his role as a significant innovator. His dedication to developing new therapeutic compounds continues to impact the medical community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…